ZimVie Inc (ZIMV) - Net Assets
Based on the latest financial reports, ZimVie Inc (ZIMV) has net assets worth $412.80 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($758.22 Million) and total liabilities ($345.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of ZimVie Inc for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $412.80 Million |
| % of Total Assets | 54.44% |
| Annual Growth Rate | -25.53% |
| 5-Year Change | -74.39% |
| 10-Year Change | N/A |
| Growth Volatility | 19.86 |
ZimVie Inc - Net Assets Trend (2019–2024)
This chart illustrates how ZimVie Inc's net assets have evolved over time, based on quarterly financial data. Also explore how large is ZimVie Inc's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for ZimVie Inc (2019–2024)
The table below shows the annual net assets of ZimVie Inc from 2019 to 2024. For live valuation and market cap data, see market value of ZimVie Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $381.71 Million | -6.79% |
| 2023-12-31 | $409.49 Million | -46.02% |
| 2022-12-31 | $758.60 Million | -47.73% |
| 2021-12-31 | $1.45 Billion | -2.62% |
| 2020-12-31 | $1.49 Billion | -10.65% |
| 2019-12-31 | $1.67 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to ZimVie Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 46663900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $277.00K | 0.07% |
| Other Comprehensive Income | $-90.56 Million | -23.73% |
| Other Components | $938.63 Million | 245.90% |
| Total Equity | $381.71 Million | 100.00% |
ZimVie Inc Competitors by Market Cap
The table below lists competitors of ZimVie Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shandong Astro-century Education&Technology Co Ltd
SHE:300654
|
$535.76 Million |
|
Esso S.A.F.
PA:ES
|
$535.78 Million |
|
Traffic Control Technology Co Ltd
SHG:688015
|
$535.91 Million |
|
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN
|
$535.97 Million |
|
HELLOFRESH UNSP.ADS/025
F:HFG0
|
$535.69 Million |
|
Invesco Municipal Trust
NYSE:VKQ
|
$535.65 Million |
|
Everjoy Health Group Co Ltd
SHE:002162
|
$535.63 Million |
|
Energy Vault Holdings Inc
NYSE:NRGV
|
$535.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ZimVie Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 409,493,000 to 381,707,000, a change of -27,786,000 (-6.8%).
- Net loss of 25,825,000 reduced equity.
- Other comprehensive income decreased equity by 17,601,000.
- Other factors increased equity by 15,640,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-25.82 Million | -6.77% |
| Other Comprehensive Income | $-17.60 Million | -4.61% |
| Other Changes | $15.64 Million | +4.1% |
| Total Change | $- | -6.79% |
Book Value vs Market Value Analysis
This analysis compares ZimVie Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.30x to 1.36x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $63.88 | $18.99 | x |
| 2020-12-31 | $57.11 | $18.99 | x |
| 2021-12-31 | $55.61 | $18.99 | x |
| 2022-12-31 | $29.08 | $18.99 | x |
| 2023-12-31 | $15.48 | $18.99 | x |
| 2024-12-31 | $13.93 | $18.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ZimVie Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.77%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.74%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.97x
- Recent ROE (-6.77%) is above the historical average (-21.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -1.67% | -2.64% | 0.50x | 1.27x | $-194.62 Million |
| 2020 | -12.01% | -19.62% | 0.47x | 1.31x | $-328.05 Million |
| 2021 | -6.57% | -9.39% | 0.56x | 1.26x | $-240.44 Million |
| 2022 | -8.42% | -6.99% | 0.56x | 2.16x | $-139.74 Million |
| 2023 | -96.04% | -85.98% | 0.38x | 2.94x | $-434.23 Million |
| 2024 | -6.77% | -5.74% | 0.60x | 1.97x | $-64.00 Million |
Industry Comparison
This section compares ZimVie Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,807,561,702
- Average return on equity (ROE) among peers: -107.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $412.80 Million | -1.67% | 0.84x | $535.72 Million |
| Abbott Laboratories (ABT) | $17.48 Billion | 27.92% | 1.43x | $150.71 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $16.66 Million |
| Aethlon Medical Inc (AEMD) | $-2.20 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $-879.00K | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $10.55 Million |
| Allurion Technologies, Inc. (ALUR) | $19.83K | -26.07% | 15.64x | $9.21 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $1.96 Million | -680.21% | 0.05x | $3.99 Million |
| Artivion Inc (AORT) | $285.70 Million | 0.60% | 1.12x | $1.13 Billion |
| Apyx Medical Inc (APYX) | $14.83 Million | -75.59% | 3.51x | $153.68 Million |
About ZimVie Inc
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solu… Read more